213 related articles for article (PubMed ID: 9753636)
1. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells.
Mandel H; Sharf R; Berant M; Wanders RJ; Vreken P; Aviram M
Biochem Biophys Res Commun; 1998 Sep; 250(2):369-73. PubMed ID: 9753636
[TBL] [Abstract][Full Text] [Related]
2. HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Mäkelä SM; Jauhiainen M; Ala-Korpela M; Metso J; Lehto TM; Savolainen MJ; Hannuksela ML
Alcohol Clin Exp Res; 2008 Jun; 32(6):991-1000. PubMed ID: 18498551
[TBL] [Abstract][Full Text] [Related]
3. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
[TBL] [Abstract][Full Text] [Related]
4. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
6. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
[TBL] [Abstract][Full Text] [Related]
8. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux.
Mulcahy JV; Riddell DR; Owen JS
Biochem J; 2004 Feb; 377(Pt 3):741-7. PubMed ID: 14570588
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
10. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
[TBL] [Abstract][Full Text] [Related]
11. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
Lin KY; Chen YL; Shih CC; Pan JP; Chan WE; Chiang AN
J Cell Biochem; 2002; 86(2):258-67. PubMed ID: 12111995
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Fallatah W; Smith T; Cui W; Jayasinghe D; Di Pietro E; Ritchie SA; Braverman N
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31862688
[TBL] [Abstract][Full Text] [Related]
13. Uptake of fluorescent plasmalogen analogs by cultured human skin fibroblasts deficient in plasmalogen.
Loidl J; Schwabe G; Paschke E; Paltauf F; Hermetter A
Biochim Biophys Acta; 1990 Nov; 1029(1):75-84. PubMed ID: 2223814
[TBL] [Abstract][Full Text] [Related]
14. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.
Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J
Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479
[TBL] [Abstract][Full Text] [Related]
15. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.
Brites P; Ferreira AS; da Silva TF; Sousa VF; Malheiro AR; Duran M; Waterham HR; Baes M; Wanders RJ
PLoS One; 2011; 6(12):e28539. PubMed ID: 22163031
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
[TBL] [Abstract][Full Text] [Related]
17. Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants.
Gaposchkin DP; Zoeller RA
J Lipid Res; 1999 Mar; 40(3):495-503. PubMed ID: 10064738
[TBL] [Abstract][Full Text] [Related]
18. Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A
Lebrero P; Astudillo AM; Rubio JM; Fernández-Caballero L; Kokotos G; Balboa MA; Balsinde J
Cells; 2019 Jul; 8(8):. PubMed ID: 31370188
[TBL] [Abstract][Full Text] [Related]
19. [Improving of HDL capacity for macrophages cholesterol efflux after plasma incubation with phospholipid nanoparticles].
Kudinov VA; Zakharova TS; Torkhovskaya TI; Kashirtseva VA; Morosevich GE; Ipatova OM; Archakov AI
Biomed Khim; 2018 Jun; 64(3):253-256. PubMed ID: 29964261
[TBL] [Abstract][Full Text] [Related]
20. On the importance of plasmalogen status in stimulated arachidonic acid release in the macrophage cell line RAW 264.7.
Gaposchkin DP; Farber HW; Zoeller RA
Biochim Biophys Acta; 2008 Apr; 1781(4):213-9. PubMed ID: 18328831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
